Markets › United States › NAS › ABUS

Arbutus Biopharma Corp

NAS:ABUSHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$4.23+0.24%At closeAt close · Tue 20 Oct · ≈ AED 15.53 · Market cap $836.9M · Next earnings Wed 11 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−586.7%	100.0%	100.0%	100.0%	100.0%	97.4%	—	—
Operating margin	−836.1%	−669.1%	−167.8%	−430.5%	−1,236.7%	−192.1%	−192.1%	+0.0 pts
Net margin	−922.0%	−693.9%	−178.0%	−401.6%	−1,133.0%	−237.9%	−237.9%	+0.0 pts
EBITDA margin	−835.3%	−652.0%	−158.5%	−391.3%	−1,108.5%	−234.6%	—	—
Return on equity	−62.5%	−45.0%	−50.8%	−68.7%	−71.8%	−43.7%	−43.7%	+0.0 pts
Return on assets	−46.5%	−37.3%	−35.5%	−50.4%	−53.1%	−35.4%	−35.4%	+0.0 pts
Return on capital employed	−45.3%	−38.0%	−40.3%	−64.1%	−65.7%	−30.5%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	16.4%	9.2%	6.4%	6.0%	4.6%	4.4%	—	—
Interest coverage	−14.4×	−25.7×	−37.9×	−170.2×	−557.1×	−278.9×	—	—
Current ratio	13.4×	14.3×	4.6×	5.9×	8.2×	15.7×	15.7×	+0.0%
Quick ratio	13.4×	14.3×	4.6×	5.9×	8.2×	15.7×	—	—
Cash ratio	5.5×	9.7×	0.9×	1.2×	2.3×	3.0×	3.0×	+0.0%
Asset turnover	0.1×	0.1×	0.2×	0.1×	0.0×	0.1×	—	—
Receivables turnover	5.3×	12.2×	28.9×	10.2×	2.6×	8.1×	—	—
Dividend payout	0.0%	−15.9%	0.0%	0.0%	0.0%	0.0%	—	—